Skip to main content
. 2017 Jul 24;28(5):e74. doi: 10.3802/jgo.2017.28.e74

Fig. 10.

Fig. 10

Princess Margaret, Chicago, and California phase II consortia: PHL86 design schema.

Cabozantinib (Cometriq™; Exelixis, Inc., South San Francisco, CA, USA).

CT, chemotherapy; ECOG, Eastern Cooperative Oncology Group; PO, per os; PS, performance score; QD, every day.